- Home
- AVXL vs ACEL Comparison
AVXL vs ACEL Comparison
Compare AVXL & ACEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVXL
- ACEL
- Stock Information
- Founded
- AVXL 2004
- ACEL 2009
- Country
- AVXL United States
- ACEL United States
- Employees
- AVXL N/A
- ACEL N/A
- Industry
- AVXL Biotechnology: Biological Products (No Diagnostic Substances)
- ACEL Services-Misc. Amusement & Recreation
- Sector
- AVXL Health Care
- ACEL Consumer Discretionary
- Exchange
- AVXL Nasdaq
- ACEL Nasdaq
- Market Cap
- AVXL 956.7M
- ACEL 1.1B
- IPO Year
- AVXL N/A
- ACEL N/A
- Fundamental
- Price
- AVXL $9.95
- ACEL $11.18
- Analyst Decision
- AVXL Strong Buy
- ACEL Buy
- Analyst Count
- AVXL 2
- ACEL 1
- Target Price
- AVXL $44.00
- ACEL $16.00
- AVG Volume (30 Days)
- AVXL 1.2M
- ACEL 431.5K
- Earning Date
- AVXL 08-12-2025
- ACEL 08-05-2025
- Dividend Yield
- AVXL N/A
- ACEL N/A
- EPS Growth
- AVXL N/A
- ACEL N/A
- EPS
- AVXL N/A
- ACEL 0.40
- Revenue
- AVXL N/A
- ACEL $1,279,563,000.00
- Revenue This Year
- AVXL N/A
- ACEL $9.34
- Revenue Next Year
- AVXL N/A
- ACEL $4.61
- P/E Ratio
- AVXL N/A
- ACEL $27.87
- Revenue Growth
- AVXL N/A
- ACEL 7.00
- 52 Week Low
- AVXL $4.93
- ACEL $9.02
- 52 Week High
- AVXL $14.44
- ACEL $13.28
- Technical
- Relative Strength Index (RSI)
- AVXL 39.87
- ACEL 40.14
- Support Level
- AVXL $9.90
- ACEL $10.10
- Resistance Level
- AVXL $11.70
- ACEL $11.49
- Average True Range (ATR)
- AVXL 0.70
- ACEL 0.40
- MACD
- AVXL -0.23
- ACEL -0.13
- Stochastic Oscillator
- AVXL 1.62
- ACEL 34.02
About AVXL Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
About ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.